Potential pharmacokinetic interactions between dapoxetine, a serotonin transporter inhibitor developed for the treatment of premature ejaculation (PE), and the phosphodiesterase-5 inhibitors ...

More than 2,600 men with moderate to severe ejaculation problems were included and either received a placebo, 30mg of dapoxetine or 60mg of dapoxetine. On average, at the start of the study, the men ...